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Abstract
Background: Spontaneous intracerebral hemorrhage (ICH) is a devastating form of stroke with the high mortality
twofold to sixfold higher than that for ischemic stroke. But the treatment of haematomas within the basal ganglia
continues to be a matter of debate among neurologists and neurosurgeons. The purpose of this study is to judge
the clinical value of minimally invasive stereotactic puncture therapy (MISPT) on acute ICH.
Methods: A prospective controlled study was undertaken. The clinical trial was in compliance with the WMA
Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects. According to the
enrollment criterion, there were 168 acute ICH cases analyzed, of which 90 cases were performed by MISPT ( MISPT
group, MG) and 78 cases by Conventional craniotomy (CC group, CG), by means of compare of Glasgow Coma
Scale(GCS) score, postoperative complications(PC) and rebleeding incidence(RI), moreover, long-term outcome of 1
year postoperation judged by Glasgow Outcome Scale (GOS), Barthel Index (BI), modified Rankin Scale (mRS) and
case fatality(CF).
Results: MG patients showed obvious amelioration in GCS score compared with that of CG. The total incidence of
PC in MG decreased obviously compared with that of CG. The incidences of rebleeding in MG and CG were 10.0%
and 15.4% respectively. There was no obvious difference between CFs of MG and CG. For three parameters
representing long-term outcome, the GOS, BI and mRS in MG were ameliorated significantly than that of CG.
Conclusion: These data suggested that the advantage of MISPT was displayed in minute trauma and safety, and
seemed to be feasible and to had a trend towards improved long-term outcome.
Trial Registration: The Australian New Zealand Clinical Trials Registry (ANZCTR), the registration number:
ACTRN12610000945022.
Background
Spontaneous intracerebral hemorrhage (ICH) comprises
in 8-30% of all stroke victims, depending on regional
and ethnic differences, and is a devastating form of
stroke with the high mortality twofold to sixfold higher
than that for ischemic stroke [1], and 1-year survival
rate less than 50%[2]. Hitherto, morbidity and mortality
following ICH remain the highest among all forms of
cerebrovascular diseases, with a 30-day mortality rate of
35% to 52%, half of the deaths occurring in the first 2
days [3-5]. After initial irreversible tissue injury is suf-
fered near the hemorrhage nidus, a progressive cascade
of elevated local pressures, edema, and excitotoxicity
causes additional secondary injury to surrounding brain
[6-8]. Secondary brain injury by hematoma often occurs
in the days following the initial hemorrhage and is
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deterioration.
Despite being considerably frequent, the treatment of
haematomas within the basal ganglia continues to be a
matter of debate among neurologists and neurosur-
geons. Present powerful evidence provided by the results
of the International Study of the Treatment of Intracra-
nial Hemorrhage (STICH) corroborates this statement
which has been established before: there was not signifi-
cant benefit for conventional aggressive surgical treat-
ment over conservative medical treatment for the acute
care of ICH [9]. Nevertheless, more than 7000 patients
with ICH in the United States ever undergo traditional
evacuation procedures each year [10].
However, various clinical studies testing the hypoth-
esis that clot burden plays a significant role in several
forms of intracranial hemorrhage have become available
in recent years which seem to suggest that clot reduc-
tion plays an important role in limiting brain edema and
additional neuronal injury, as well as in reducing the
severity of neurological deficits following ICH [11-14].
Because of being attributed to the lack of validated ther-
apeutic options for this form of stroke, the role of mini-
mally invasive surgery (MIS) in the treatment of ICH
has gained importance, and emerged several differrent
operation methods over the past decade. In this context,
our treatment with a stereotactic technique, which we
have termed the minimally invasive stereotactic punc-
ture therapy (MISPT), is herewith presented.
MISPT is a novel operative technique for ICH, which
is developed by Pro Jia of China in 1997. Although sev-
eral clinical studies on MISPT in acute phase of ICH
are well recognized in the past decade, the impact of
MISPT in short-term and long-term on neurological
function of patients who survive the acute phase is less
clear. The purpose of the present study was to investi-
gate whether MISPT could maintain long-term benefit
as short-term benefit and whether this method could
improve ultimate outcomes in these ICH patients.
Therefore we compared the long-term outcome one
year after treatment obtained in a consecutive series of
ICH patients treated by MISPT with the results achieved
in a comparable group of patients who were treated by
conventional craniotomy (CC).
Methods
A prospective controlled study was undertaken. All ICH
patients came from in-hospital from 2005 to 2008, diag-
nosed as ICH according to the ICH criteria of which is
drafted by ASA [15]. The clinical trial was in compli-
ance with the WMA Declaration of Helsinki - Ethical
Principles for Medical Research Involving Human Sub-
jects, and was performed with the approval of our hos-
pital ethics committee(Reference number: JSCS2005058).
We generated the sequence for enrolling a subject and
allocating the treatment by a randomized number gener-
ated by computer. All cases have been monitored in a
dedicated stroke unit. Volume of the ICH in milliliters
was estimated on the basis of approximate ellipse
volume with the A×B×C/2 formula, where A represents
the largest diameter of the hematoma on axial CT cuts
in centimeters, B the diameter of hematoma perpendicu-
l a rt oAo nt h es a m ec u t ,a n dCt h en u m b e ro fC T
slices in which hematoma is visible multiplied by the
slice thickness in centimeters [16,17].
Inclusion and exclusion criteria for patients
Inclusion criteria were as follows
(1) diagnosed as having spontaneous hemorrhage in the
basal ganglion or brain lobe of the brain by CT scan; (2)
hemorrhage volume: 30-100 ml; (3) age range: 40-75
years; (4) muscle strength of the paralyzed limbs: grades
0-3 on the muscle strength scale; (5) hemorrhagic dura-
tion (from stroke onset to hospital) within 24 h; (6)
informed consent from patients and/or their law
representative.
Exclusion criteria were as follows
(1) disturbances of blood coagulation, such as thrombo-
cytopenia, hepatitis, etc; (2) traumatic intracranial
hemorrhage; (3)intracranial or general infection; (4)
complicated with serious heart, liver, renal or lung dis-
ease or functional failure; (5) a previous stroke history
with neurological deficits; (6) intracranial aneurysm or
arteriovenous malformation complicated with hemor-
rhage; (7) consent form cannot be obtained from the
patient herself or her law representative.
Treatment methods
Minimally invasive stereotactic puncture and thrombolysis
therapy (MISPT)
All operations were performed under local anesthesia
and intravenous sedation unless the patient was already
intubated for medical or neurological indications inde-
pendent of the procedure. Stereotactic aspiration of the
haematomas was performed in the acute phase between
the 6th and the 24th hour after onset of stroke refer to
MISPT guide. Firstly, the target points was defined
according to the computer tomography and mostly target
points were chosen in the scan with the largest expansion
of the haematoma(shown in Figure 1). Puncture situs was
measured and marked on head noticing to get out of the
way of main blood vessel, then puncture needle of suita-
ble length(Type YL-1) was fixed on the operative electric
drill. The puncture needle was perforated into predeter-
mined depth, then the probe core removed, hematoma
drawn out gently by syringe (diluted by saline solution if
blood thicken) until 1/3 of hematoma were removed,
needle-like hematoma disintegrator inserted. When no
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thoroughly rinsed with saline, until the saline fluid could
be re-aspirated clearly.
To confirm gross haematoma evacuation, an immedi-
ate postoperative CT scan was taken for assessment of
puncture needle placement and residual hematoma
volume. If the placement of puncture needle is in the
center of hematoma and stable, without rebleeding, the
drainage-bag maintained 10 cm upon the head was
linked to the puncture needle and switched for drainage.
Once rebleeding, 1ku reptilase or 1 mg adrenalin should
be injected into hematoma, drained after 0.5 h, and
rinsed after 6-8 h. All patients were administered in a
dedicated intensive care unit, where subsequent throm-
bolysis and clot drainage were performed at the bedside
using sterile technique. Hematoma was continuiosly
liquefied by liquefacient (containing 20000U-40000U
urokinase/2-3 mL saline solution) for 2-4 days (3-5
times per day). In the 1st,3rd,5th and 7th day of post-
operation, patients were re-examined the computer
tomography. For haematoma difficulty to aspirate, it
should be liquefied as far as possible at first and repeat-
edly aspirated using agitation manoeuvre of liquefacient
to form performance vacuity. Haematoma breaking into
one lateral cerebral ventricle should be perforated only
haematoma cavity, but for those of haematoma breaking
into both lateral cerebral ventricle and casting mould,
haematoma cavity and opposite side lateral cerebral ven-
tricle should be perforated simultaneously.
In addition, lumbar puncture could be performed to
repeatedly replace cerebral spinal fluid using NS until
color pale for 4-5 days (one time per day). When the
hematoma was basically cleared or the reminder volume
were less than 10 ml, the general condition of patients
were stable, and intracranial pressure were normal by
lumbar puncture, the puncture needle could be pull out
if without intracranial hypertension after drainage tube
occluded for 24 h. The puncture needle was removed at
the bedside under sterile technique, and a single suture
was placed at its exit site and covered with an occlusive
dressing. Additionally, all patients received routine med-
ical treatment.
Conventional craniotomy(CC)
After 6-24 h of onset, clearance of hematoma by tradi-
tional craniotomy with large bone flap removed was
operated in Department of Neurosurgery. The surgery
was assessed by postoperative CT to determine if it was
successful or not. Meantime, the routine medical treat-
ment was performed.
Complications observation
To comparing its therapeutic effect, several main clinical
complications including pulmonary infection, digestive
tract hemorrhage and epilepsy were observed two week
postoperation. Meanwhile, incidence of complication
and rebleeding observation were also carried out.
Follow-Up and Outcome Assessment
Evaluation of all patients followed identical criteria.
Initial assessment included baseline characteristics (age,
gender, haematoma volume, et al). The pretreatment
clinical state of this cohort was assessed according to
the GCS. All cases between two groups could be
matched each other with regard to baseline characteris-
tics. The posttreatment clinical state of patients was
assessed according to the GSC score, incidence of com-
plication, recurrence of bleeding after surgery. Outcome
1 year after stroke was the major endpoint. Four out-
come parameters commonly used to assess outcome
were employed to study the full impact of haemorrhagic
stroke on long-term follow-up. Total case fatality was
defined 1 year after stroke. According to the Glasgow
Outcome Scale (GOS), clinical outcomes were graded,
ranging from good recovery (GOS 5) to dead (GOS 1).
The performance and functional status of the patients in
activities of daily living (ADL) were measured with the
Barthel Index (BI). Handicap was assessed using the
modified Rankin Scale (mRS). The datas of all four out-
come parameters for two treatment groups were ana-
lysed and compared.
Figure 1 The slice of the largest hematoma area and puncture
point in the CT are illustrated. AB median sagittal line, CD
precoronal line, EF lateral sagittal line, P puncture point of
hematoma, H center of hematoma, G puncture point of lateral
cerebral ventricle, PH puncture depth, L lateral cerebral ventricle
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Categorical variables were analysed using c
2 test or Fish-
er’s exact test for small numbers. Measurement data
were analysed using T-tests. All recorded data were
input using Epi Info software and statistically analysed
using SPSS 11.5 statistical software. For all analyses, p <
0.05 was considered to be statistically significant.
Results
There were 168 patients analyzed, of which 90 cases
were treated with MISPT and 78 cases with CC. There
were no statistically significant difference in sex, age,
GCS score, localization of bleeding, hemorrhage volume,
the level of blood pressure while hospitalization and
duration of hypertension in the three groups (shown in
Table 1).
Comparison of consciousness level after surgery, GCS
score and the incidence of complications between the
two groups
The GCS score had no significant difference between
two groups before operation(8.1 ± 2.3 and 8.4 ± 3.2
respectively, P = 0.523). The total incidence of complica-
tion in the MISPT group was lower than that of the CC
group (32.3% and 80.7% respectively, P = 0.001). Pul-
monary infection(8.9%), digestive tract hemorrhage
(17.8%) and epilepsy(5.6%) in the MISPT group were all
lower than that of the CC group (21.8%, 39.7% and
19.2%, respectively) (P = 0.029, P = 0.002 and P = 0.036,
respectively). The incidence of bleeding recurrence had
no significant difference between two groups (10.0% and
15.4% respectively, P = 0.051) (shown in Table 2).
According to post-operative imaging findings, about 70-
80% of haematoma could be removed in the MISPT
group. There were some typical examples in this study.
For example, CT scans of one coma patient (GCS score
6)with a huge haematoma (> 70 mL) were shown(Figure
2). It was clear that there were obvious difference in
haematoma volume and edema of surrounding brain
before MISPT with consciousness of GCS score 5 and 2
weeks after MISPT with consciousness of GCS score 14.
The patient achieved self-care living 1 year after on-set
(shown in Figure 2).
Comparison of long-term outcome and total case fatality
of two groups 1 year after stroke
Although there was no sharp difference in case fatality
between MISPT group and CC group 1 year after stroke
(18.9% and 24.4% respectively, P = 0.096), the results
showed that the recovery of survival in MISPT group
was significantly better than that of the CC group
according to the assession results of GOS, mRS and BI
(GOS, P = 0.000; mRS, P = 0.001; BI, P = 0.000, respec-
tively). (shown in Table 3).
Discussion
The mass effect of hematoma can lead to the brain
damage such as intracranial hypertension or cerebral
hernia [18]. But there were some evidences shown that
the mass effect caused by hematoma volume(< 60 ml)
w a sn o tt h ed o m i n a n ti n j u r ym e c h a n i s m ,w h e r e a st h e
toxic substances released from the hematoma were the
most important factor in the pathological mechanism of
the cerebral hemorrhage [19-21]. It was reported that
Table 1 The Baseline Characteristics of Patients
Group MISPT
patients
CC
patients
P
value
Number of patients 90 78
Gender (m:f) 59:31 50:28 0.844
Mean age (years) 57.6 ± 11.2 59.2 ± 10.7 0.341
GCS score (n/%) 0.885
4-5 7/7.8 8/10.3
6-9 38/42.2 35/44.9
10-12 27/30.0 20/25.6
13-15 18/20.0 15/19.2
Mean haematoma volume (n/%) 0.856
30-59(mL) 33/36.7 26/33.3
60-79(mL) 30/33.3 29/37.2
80-100(mL) 27/30.0 23/29.5
Direction of the haematoma (n/
%)
0.550
Left-sided 48/53.3 38/51.3
Right-sided 42/46.7 40/48.7
Location of the haematoma (n/
%)
0.571
Basal ganglia 48/53.3 39/50.0
Deep brain lobe 26/28.9 20/25.6
Thalamus 16/17.8 19/24.4
Mean BP
SBP 174.5 ± 13.2 172.9 ±
11.5
0.414
DBP 102.2 ± 8.3 99.2 ± 7.6 0.361
Duration of BP (years) 6.7 ± 2.0 7.1 ± 2.4 0.219
Table 2 Consciousness Level after Surgery, GCS Score
and Incidence of Complication of Two Groups
Group MISPT
patients
CC
patients
P
value
Number of patients
GCS score
90 78
before operation 8.1 ± 2.3 8.4 ± 3.2 0.523
after operation 10.5 ± 0.9 8.0 ± 0.6 0.039
incidence of complication(n/%) 29/32.3 63/80.7 0.000
pulmonary infection 8/8.9 17/21.8 0.019
digestive tract
hemorrhage
16/17.8 31/39.7 0.002
epilepsy 5/5.6 15/19.2 0.006
Bleeding recurrence (n/%) 9/10.0 12/15.4 0.293
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tomal region after ICH and were decreased during
hematoma drainage. Conversely, ischemic LPRs were
not found in perihematomal regions and were
unchanged during hematoma drainage. These data sug-
gest that excitotoxicity related to glutamate may have an
important impact on secondary injury. The data failed
to support the role of ischemia in secondary perihema-
tomal damage [6].
Therefore, effective removal of hematoma at the acute
phase is the crucial principle of treatment with ICH for
saving life and improving the long-term quality of life.
CC by removing bone flap is the classical technique
treating ICH which is characterized by good view, clear-
ance of hematoma completely, easy haemostasia, and
the entire reduction of pressure, but also have some
shortcomings such as taking long time to operate,
damaging brain severely, being subject to pulling the
brain in the operation, the brain tissue around the
hematoma readily damaged by electrocoagulation, re-
bleeding readily, producing a series of pathophysiologi-
cal changes in post-operation (such as disturbance of
water and electrolyte, fluctuation of blood sugar,
instability of life signs and so on), which resulting in
severe impairment of neurological function, multiple
complications, higher invalidism rate and fatality rate.
With regard to basal ganglia haemorrhages, comparing
the outcome of patients treated surgically with that of
patients managed conservatively, many earlier and cur-
rent publications showed no b e n e f i tf r o mc o n v e n t i o n a l
surgery [9,10,22-25]. Correspondly this disappointing
results, only a few reports have demonstrated a trend
towards better outcomes in conventional surgical group
[26-28]. While analysing the given data, it becomes
obvious that the major problem in all these studies is
the heterogeneity of the ICH patient groups with regard
to their preoperative neurological status with quite dif-
ferent degrees of neurological impairment and not uni-
form consciousness levels, applying different surgical
approaches and different intervals with regard to the
onset of haemorrhagic stroke. Thus it is an essential
issue to select appropriate patients and homogenous
group for determining whether patients truly benefit
from neurosurgical or not treated by stereotactic eva-
cuation of the haematomas in the acute phase. In many
recent studies the minimally-invasive method have
shown to be highly efficient with little risk of re-bleed-
ing and better short-term outcome [29-31]. Presently,
some clinicians are exploring new methods to elevate
curative effect of minimally-invasive operation techni-
que. A study by Marquardt and coworkers focused on
the use of a novel multiple target aspiration technique
in 64 patients to aspirate a “sufficient proportion” of the
Figure 2 CT scans of one patient in a coma(GCS score 6)with a huge haematoma(> 70 mL) before MISPT(upper), and CT scans of the
same patient in consciousness (GCS score 14) 2 weeks after completed MISPT with urokinase (lower). All scans demonstrate a series size
of hematoma on axial imaging.
Table 3 Outcome 1 Year after Stroke of Two Groups
Group MISPT patients CC patients P value
Number of patients 90 78
case fatality(n/%) 17/18.9 19/24.4 0.389
GOS 4.3 ± 0.4 2.6 ± 0.3 0.043
mRS 2.2 ± 0.3 3.9 ± 0.4 0.042
BI 79.5 ± 11.1 62.0 ± 9.8 0.011
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80% of the hematoma volume was successfully aspirated
in 73.4% of the patients with only one episode of re-
bleeding [32]. Jose’s study showed that CT-guided
thrombolysis and aspiration was safe and effective in the
reduction of ICH volume. But meantime they proposed
further studies were needed to assess optimal thrombo-
lytic dosage and must include controlled comparisons of
mortality, disability outcome time until convalescence,
and cost of care in treated and untreated patients [33].
MISPT is a new and novel operative technique
obviously differrent from other various kinds minimally-
invasive operations in design principle, which is devel-
oped by Pro Jia from China in 1994 with a distinctive
thrombolysis installation, and highly safe and efficient
functions of dissolving and draining coagulated blood.
This treatment had been widely applied in China.
According to some study in the past, it was presented
that MISPT in acute ICH could efficiently clear hema-
toma, relieve hydrocephalus, drop the intracranial hyper-
tension, and relieve the cytotoxicity of blood thrombin.
Furthermore, the washing liquor could decrease the
cytotoxic substances. In subacute hemorrhage, MISPT
could reduce the neurotoxicity of the hemoglobin and
its disaggregation such as ferri ion. This technique is
characterized by its simple operation, not limited by
equipment. The puncture of MISPT is little harmful for
the brain, and profit the recovery of cerebral function,
and the liquefaction technique contribute to the blood
coagulum liquefied, which all help shorten the course of
disease. In the whole procedure of the operation,
patients were only treated with the puncture of 3 mm
needle in diameter. Because of no gap between the nee-
d l ea n ds k u l l ,w h i c hr e d u c et h ei n c i d e n c eo fi n f e c t i o n .
Furthermore, it is not needed to open the skull and
anesthetize generally, and being cheaper than other
operations. Chinese National Research and Extension
Community of the MinimallyI n v a s i v eO p e r a t i o ns u g -
gested that MISPT is suitable to the cases that have
hemorrhage volume > 30 mL in basal ganglia, and
further standardize the operation indication, operation
procedure and the applying methods of the hematoma
liquefacient according to the random sampling of The
Ministry of Public Health [34].
Although there being many studies to investigate the
minimally invasive operation indication of ICH, few spe-
cially concerned indicatio of the MISPT. Furthermore,
most of these investigations didn’t establish the control
groups strictly with uniform baseline characteristics
patients on preoperation, analyze the correlation factors
such as GCS score, hematoma volume, haematoma loca-
tion, duration of BP and observe the long-term outcome
for survival. In our study, above shortcomings in
research were overcame with many factors being
considered including preoperative neurological status,
surgical approaches and opportunity applied, GCS score,
incidence of complication and rebleeding incidence after
surgery, long-term outcome 1 year after onset and so
on. The result showed that the level of consciousness
and GCS in MISPT were better than that of the CC
group. There were 17 cases died in 20 patients with 4-5
GCS score in two groups(the ratio is 85.0%), the 3 survi-
vor all treated with MISPT (table 1, one case referring
to figure 2). The incidence of complications such as pul-
monary infection, hemorrhage of digestive tract, and
epilepsy in MISPT was obviously reduced compare to
CC group. There were no cases of intracranial infection
both in MISPT and the craniotomy group. The statisti-
cal analysis did not show the significant difference on
the rebleeding incidence in the two groups(10.0% and
15.4% respectively, P = 0.151). There were no obviously
difference between the case fatalities of MISPT group
and CC group(18.9% and 24.4% respectively, P = 0.096).
The long-term outcome of MISPT group surpassed over
that of CC group according to the results of GOS, mRS
and BI. (GOS, P = 0.000; mRS, P = 0.001; BI, P = 0.000).
In present, there were some exploration on thrombo-
lysis methods. We used UK as thrombolysis methods in
our MISPT study. Otherwise, in another cohort of ICH
patients treated using FAST, volumetric analysis of ICH
and perihematomal edema seems to suggest that local
use of rtPA as thrombolysis which differed from UK
used in our MISPT does not exacerbate brain edema
formation. Furthermore, there seems to be a strong
association between reduction in ICH volume and
reduction in edema volume, as would be expected fol-
lowing the concept of ‘’hemotoxicity’’ postulated by
some investigators [35].
These above results indicated that the ICH patient
meeting MISPT operation indication was unsuitable to
choose CC. However, the patient with huge hemorrhage
volume, or the state of illness progress rapidly, or in the
early state of cerebral hernia should select the craniot-
omy to reduce the cerebral pressure. By the way, Some
study have point out that although MIS on the patients
with cerebral hernia may not get good curative effect,
which can decrease the hematoma volume partly and
reduce the intracranial pressure rapidly, and gain time
for craniotomy [33]. Of course, CC has sometimes its
superiority in treating ICH with bulk volume. Murthy
combined the reduction pressure of removal bone flag
and the clearance of hematoma to cure 12 patients with
hemorrhage volume > 60 ml in the right hemisphere. As
ar e s u l t ,1 1s u r v i v o r sw e r eo u to ft h eh o s p i t a l( 9 2 %o f
the survival rate), 6 cases of the survivors recovered well
[36].
In conclusion, although larger randomized trials prov-
ing more relative benefits of MISPT treatment over
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are in process yet. However, our study and some other
treatment trials about this treatment modality are rising
with optimistic results superior over CC or PMT. Sev-
eral methodological issues surrounding this form of
treatment remain to be resolved, including comparison
of the relative efficacies of various mechanisms of clot
thrombolysis and drainage. If successful, MISPT for ICH
perhaps becomes an important tool in the growing
treatment armamentarium for ICH and with the poten-
tial for a disease modifying impact on these ICH
patients. It is our hope that this ongoing study will
bring us closer to other randomized testings regarding
to more relevant factors with MISPT as an alternative
treatment for ICH. Objectively, this MISPT are limited
in their ability to achieve hemostasis and completely
evacuate the hematoma. Proper selection of the ICH
patient group in which to apply these therapies may
hold the key to these advances.
Conclusions
These data suggested that MISPT displayed its advan-
tage in minute trauma and safety, and was feasible and
to had a trend towards improved long-term outcome
compared with conventional craniotomy.
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